Literature DB >> 30227213

METase promotes cell autophagy via promoting SNHG5 and suppressing miR-20a in gastric cancer.

Lin Xin1, Li-Qiang Zhou2, Li Liu2, Yi-Wu Yuan2, Hou-Ting Zhang2, Fei Zeng2.   

Abstract

BACKGROUND: Gastric cancer (GC) severely threatens human life, and METase seemed to inhibit tumor growth. However, the potential mechanism underlying it is still unclear.
METHODS: Both clinical tissues and cell lines were used in the present study. SNHG5 and miR-20a expressions were determined using real-time PCR. Western blot was performed to determine the expression of autophagy-related proteins. The interaction between miR-20a and SNHG5 was determined using luciferase reporter assay and RNA immunoprecipitation (RIP).
RESULTS: The expression of SNHG5 was decreased in GC tissues and cell lines. Overexpressed METase significantly promoted cell apoptosis and autophagy, as well as the expression of SNHG5. SNHG5 directly regulated the expression of miR-20a. GC cells transfected with pcDNA-SNHG5 significantly promoted cell apoptosis and autophagy, while the co-transfected with miR-20a mimic dramatically reversed the effects of pcDNA-SNHG5. Overexpressed METase significantly promoted cell autophagy, which was abolished by down-regulated SNHG5.
CONCLUSION: Overexpressed METase promoted cell apoptosis and autophagy via up-regulating the expression of SNHG5 and down-regulating miR-20a in GC.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophgy; Gastric cancer; METase; SNHG5; miR-20a

Mesh:

Substances:

Year:  2018        PMID: 30227213     DOI: 10.1016/j.ijbiomac.2018.09.051

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  10 in total

1.  METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy.

Authors:  Lin Xin; Qi Zhou; Yi-Wu Yuan; Li-Qiang Zhou; Li Liu; Shi-Hao Li; Chuan Liu
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-04       Impact factor: 4.553

2.  Expression and clinical significance of miR-338 and miR-20a in serum of patients with gastric carcinoma.

Authors:  Min Li; Jueping Feng; Chang Gao; Wen Sun; Yilian Chen
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 3.  Facing Cell Autophagy in Gastric Cancer - What Do We Know so Far?

Authors:  Ting Xiu; Qie Guo; Fan-Bo Jing
Journal:  Int J Gen Med       Date:  2021-05-03

4.  Long non-coding RNA SNHG5 promotes glioma progression via miR-205/E2F3 axis.

Authors:  Xiaojian Li; Liang Liu; Yidan Luo; Sitong Cui; Wei Chen; Ailiang Zeng; Yan Shi; Liangsheng Luo
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

Review 5.  MicroRNAs play an essential role in autophagy regulation in various disease phenotypes.

Authors:  Yunyi Zhao; Ze Wang; Wenhui Zhang; Linbo Zhang
Journal:  Biofactors       Date:  2019-08-16       Impact factor: 6.113

Review 6.  Long non-coding small nucleolar RNA host genes in digestive cancers.

Authors:  Huan Yang; Zheng Jiang; Shuang Wang; Yongbing Zhao; Xiaomei Song; Yufeng Xiao; Shiming Yang
Journal:  Cancer Med       Date:  2019-11-06       Impact factor: 4.452

Review 7.  Potential Therapeutic Action of Autophagy in Gastric Cancer Managements: Novel Treatment Strategies and Pharmacological Interventions.

Authors:  Md Ataur Rahman; Kazi Rejvee Ahmed; Md Hasanur Rahman; Moon Nyeo Park; Bonglee Kim
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

8.  Long non-coding RNA SNHG5 promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the miR-212-3p/GDF5/SMAD pathway.

Authors:  Yineng Han; Qiaolin Yang; Yiping Huang; Lingfei Jia; Yunfei Zheng; Weiran Li
Journal:  Stem Cell Res Ther       Date:  2022-03-28       Impact factor: 6.832

Review 9.  Autophagy Related Noncoding RNAs: Emerging Regulatory Factors of Gastric Cancer.

Authors:  Ling Lu; Qiaoyan Liang; Xinyi Zhang; Yumeng Xu; Dehua Meng; Zhaofeng Liang
Journal:  Cancer Manag Res       Date:  2022-07-19       Impact factor: 3.602

Review 10.  The Emerging Role of Circ-SHPRH in Cancer.

Authors:  Xinyue Ju; Yan Tang; Rongfeng Qu; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2021-07-13       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.